Follow
Hamdy Abdelkader, PhD
Hamdy Abdelkader, PhD
Lecturer in Pharmaceutics, Minia University
Verified email at minia.edu.eg
Title
Cited by
Cited by
Year
Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations
H Abdelkader, AWG Alani, RG Alany
Drug delivery 21 (2), 87-100, 2014
3122014
Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery
H Abdelkader, S Ismail, A Kamal, RG Alany
Journal of pharmaceutical sciences 100 (5), 1833-1846, 2011
1802011
New therapeutic approaches in the treatment of diabetic keratopathy: a review
H Abdelkader, DV Patel, CNJ McGhee, RG Alany
Clinical & experimental ophthalmology 39 (3), 259-270, 2011
1162011
Corticosteroids in ophthalmology: Drug delivery innovations, pharmacology, clinical applications, and future perspectives
SA Gaballa, UB Kompella, O Elgarhy, AM Alqahtani, B Pierscionek, ...
Drug Delivery and Translational Research 11, 866-893, 2021
1142021
Formulation of controlled-release baclofen matrix tablets: Influence of some hydrophilic polymers on the release rate and in vitro evaluation
H Abdelkader, OY Abdalla, H Salem
Aaps pharmscitech 8, 156-166, 2007
1092007
Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone
PME Gaafar, OY Abdallah, RM Farid, H Abdelkader
Journal of liposome research 24 (3), 204-215, 2014
942014
Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models
H Abdelkader, S Ismail, A Hussein, Z Wu, R Al-Kassas, RG Alany
International journal of pharmaceutics 432 (1-2), 1-10, 2012
942012
Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects
H Abdelkader, Z Wu, R Al-Kassas, RG Alany
International journal of pharmaceutics 433 (1-2), 142-148, 2012
892012
Age-related cataract and drug therapy: opportunities and challenges for topical antioxidant delivery to the lens
H Abdelkader, RG Alany, B Pierscionek
Journal of Pharmacy and Pharmacology 67 (4), 537-550, 2015
882015
Cubosomes: composition, preparation, and drug delivery applications.
SA Gaballa, OH El Garhy, H Abdelkader
Journal of advanced biomedical and pharmaceutical sciences 3 (1), 1-9, 2020
872020
Controlled and continuous release ocular drug delivery systems: pros and cons
H Abdelkader, R G Alany
Current drug delivery 9 (4), 421-430, 2012
812012
Phytosome-hyaluronic acid systems for ocular delivery of L-carnosine
H Abdelkader, MR Longman, RG Alany, B Pierscionek
International journal of nanomedicine, 2815-2827, 2016
742016
Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization
H Abdelkader, S Ismail, A Kamal, RG Alany
Die Pharmazie-An International Journal of Pharmaceutical Sciences 65 (11 …, 2010
742010
Formulation of Controlled-Release Baclofen Matrix Tablets II: Influence of Some Hydrophobic Excipients on the Release Rate and In Vitro Evaluation
H Abdelkader, O Youssef Abdalla, H Salem
Aaps Pharmscitech 9, 675-683, 2008
702008
Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis
FM Mady, H Essa, T El-Ammawi, H Abdelkader, AK Hussein
Drug design, development and therapy, 1101-1110, 2016
672016
The suprachoroidal pathway: a new drug delivery route to the back of the eye
UDJP Rai, SA Young, TR Thrimawithana, H Abdelkader, AWG Alani, ...
Drug discovery today 20 (4), 491-495, 2015
612015
Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: Inserts, patches, wafers, and implants
H Abdelkader, Z Fathalla, A Seyfoddin, M Farahani, T Thrimawithana, ...
Advanced drug delivery reviews 177, 113957, 2021
592021
Cyclodextrin enhances corneal tolerability and reduces ocular toxicity caused by diclofenac
H Abdelkader, Z Fathalla, H Moharram, TFS Ali, B Pierscionek
Oxidative medicine and cellular longevity 2018, 2018
592018
Critical appraisal of alternative irritation models: three decades of testing ophthalmic pharmaceuticals
H Abdelkader, B Pierscionek, M Carew, Z Wu, RG Alany
British medical bulletin 113 (1), 59-71, 2015
482015
Novel in situ gelling ocular films for the opioid growth factor-receptor antagonist-naltrexone hydrochloride: Fabrication, mechanical properties, mucoadhesion, tolerability and …
H Abdelkader, B Pierscionek, RG Alany
International journal of pharmaceutics 477 (1-2), 631-642, 2014
472014
The system can't perform the operation now. Try again later.
Articles 1–20